Equine IL-6 antibody and antigen (recombinant protein)

Diagnostic anti-Equine IL-6 antibodies pairs and antigen for animal health (animal Equine/Horse systemic juvenile idiopathic arthritis, systemic lupus erythematosus, ankylosing spondylitis, psoriasis and Crohn's disease.) testing in ELISA, colloidal gold-based Lateral flow immunoassay (LFIA), CLIA, TINIA and POCT

Target products collectionGo to Neurodegenerative diseases diagnostics products collection >>


Product information

Catalog No. Description US $ Price (per mg)
GMP-EQU-IL-6-Ag01 Recombinant Equine IL-6 protein 3090
GMP-EQU-IL-6-Ab01 Anti-Equine IL-6 mouse monoclonal antibody (mAb) 1953
GMP-EQU-IL-6-Ab02 Anti-Equine IL-6 mouse monoclonal antibody (mAb) 1953
GMP-EQU-IL-6-Ab03 Anti-Equine IL-6 human monoclonal antibody (mAb) 1953
GMP-EQU-IL-6-Ab04 Anti-Equine IL-6 human monoclonal antibody (mAb) 1953

Size: 1mg | 10mg | 100mg



Product Description

Cat No. of Products GMP-EQU-IL-6-Ag01
Product Name Recombinant Equine IL-6 protein
Target/Biomarker Equine Interleukin 6 (IL-6)
Expression platform E.coli
Isotypes Recombinant Antigen
Bioactivity validation Anti-Equine Interleukin 6 antibodies binding, Immunogen in Sandwich Elisa, lateral-flow tests, and other immunoassays as control material in IL-6 level test of animal Equine/Horse with systemic juvenile idiopathic arthritis, systemic lupus erythematosus, ankylosing spondylitis, psoriasis and Crohn's disease..
Tag His
Products description Recombinant Equine IL-6 protein was expressed in E.coli - based prokaryotic cell expression system and is expressed with 6 HIS tag at the C-terminus.
Purity Purity: ≥95% (SDS-PAGE)
Application Paired antibody immunoassay validation in sandwich Elisa, ELISA, colloidal gold-based Lateral flow immunoassay (LFIA), CLIA, TINIA, POCT and other immunoassays
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Cat No. of Products GMP-EQU-IL-6-Ab01, GMP-EQU-IL-6-Ab02
Product Name Anti-Equine IL-6 mouse monoclonal antibody (mAb)
Target/Biomarker Equine Interleukin 6 (IL-6)
Expression platform CHO
Isotypes Mouse IgG
Bioactivity validation Recombinant Equine Interleukin 6 antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other anti-IL-6 antibodies in IL-6 level test of animal Equine/Horse with systemic juvenile idiopathic arthritis, systemic lupus erythematosus, ankylosing spondylitis, psoriasis and Crohn's disease..
Tag mFc
Products description Anti-Equine IL-6 mouse monoclonal antibody (mAb) is a monoclonal antibody produced by CHO technology. The antibody is ELISA validated as capture antibody and detection antibody. Pair recommendation with other anti-IL-6 antibodies.
Purity Purity: ≥95% (SDS-PAGE)
Application Paired antibody immunoassay validation in sandwich Elisa, ELISA, colloidal gold-based Lateral flow immunoassay (LFIA), CLIA, TINIA, POCT and other immunoassays
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Cat No. of Products GMP-EQU-IL-6-Ab03, GMP-EQU-IL-6-Ab04
Product Name Anti-Equine IL-6 human monoclonal antibody (mAb)
Target/Biomarker Equine Interleukin 6 (IL-6)
Expression platform CHO
Isotypes Human IgG1
Bioactivity validation Recombinant Equine Interleukin 6 antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other anti-IL-6 antibodies in IL-6 level test of animal Equine/Horse with systemic juvenile idiopathic arthritis, systemic lupus erythematosus, ankylosing spondylitis, psoriasis and Crohn's disease..
Tag hFc
Products description Anti-Equine IL-6 human monoclonal antibody (mAb) is a monoclonal antibody produced by CHO technology. The antibody is ELISA validated as capture antibody and detection antibody. Pair recommendation with other anti-IL-6 antibodies.
Purity Purity: ≥95% (SDS-PAGE)
Application Paired antibody immunoassay validation in sandwich Elisa, ELISA, colloidal gold-based Lateral flow immunoassay (LFIA), CLIA, TINIA, POCT and other immunoassays
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Validation Data


    Click to get more Data / Case study about the product.



    Target/Biomarker information

    Interleukin-6 (IL-6) stands as a multifaceted cytokine in the realm of equine health, playing a pivotal role in immune regulation and inflammation management. This biomarker is produced by a diverse array of cells, including white blood cells (leukocytes), macrophages, and fibroblasts, in response to various physiological stimuli. In horses, IL-6's functions are diverse and context-dependent. It serves as both a pro-inflammatory and anti-inflammatory cytokine, responding dynamically to the body's needs. During acute infections or tissue injuries, IL-6 is released to trigger an immediate immune response, recruiting immune cells to the site of infection or injury and enhancing their activity. Moreover, IL-6 supports the liver in producing acute-phase proteins, which are essential for the body's defense mechanisms. However, it's essential to note that prolonged or excessive IL-6 production can lead to chronic inflammation, which is implicated in various diseases, including autoimmune disorders and certain cancers. Dysregulation of IL-6 is associated with health issues, making its measurement in horses a valuable diagnostic tool. IL-6 levels can be assessed through blood tests, allowing veterinarians to gauge a horse's immune status and inflammatory state. Elevated levels of IL-6 often indicate the presence of inflammation, infections, autoimmune diseases, or other underlying health issues in horses.



    About GDU


    GDU

    GDU helps global diagnostic partners in high quality of raw material discovery, development, and application. GDU believes in Protein&antibody Innovation for more reliable diagnostic solutions.

    Comments


    No comments yet.

    Leave a comment